A detailed history of Cliftonlarsonallen Wealth Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cliftonlarsonallen Wealth Advisors, LLC holds 21,693 shares of ABBV stock, worth $3.81 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
21,693
Previous 10,339 109.82%
Holding current value
$3.81 Million
Previous $1.77 Million 141.57%
% of portfolio
0.1%
Previous 0.04%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$163.84 - $199.33 $1.86 Million - $2.26 Million
11,354 Added 109.82%
21,693 $4.28 Million
Q2 2024

Jul 11, 2024

BUY
$154.79 - $180.76 $1.6 Million - $1.87 Million
10,339 New
10,339 $1.77 Million
Q2 2022

Jul 08, 2022

SELL
$137.62 - $174.96 $1.38 Million - $1.75 Million
-10,028 Closed
0 $0
Q1 2022

Apr 27, 2022

BUY
$131.98 - $163.75 $1.32 Million - $1.64 Million
10,028 New
10,028 $1.63 Million
Q4 2021

Jan 26, 2022

SELL
$107.43 - $135.93 $766,513 - $969,860
-7,135 Closed
0 $0
Q3 2021

Nov 02, 2021

BUY
$106.4 - $120.78 $759,164 - $861,765
7,135 New
7,135 $770,000
Q3 2021

Oct 14, 2021

SELL
$106.4 - $120.78 $753,950 - $855,847
-7,086 Closed
0 $0
Q2 2021

Jul 21, 2021

BUY
$105.21 - $117.21 $745,518 - $830,550
7,086 New
7,086 $798,000
Q1 2019

Apr 09, 2019

SELL
$77.14 - $90.79 $1 Million - $1.18 Million
-13,022 Closed
0 $0
Q4 2018

Jan 22, 2019

SELL
$77.85 - $96.01 $4,593 - $5,664
-59 Reduced 0.45%
13,022 $1.2 Million
Q3 2018

Nov 05, 2018

BUY
$88.91 - $98.84 $27,295 - $30,343
307 Added 2.4%
13,081 $1.24 Million
Q2 2018

Jul 23, 2018

BUY
$89.78 - $106.23 $146,700 - $173,579
1,634 Added 14.67%
12,774 $1.18 Million
Q1 2018

Apr 26, 2018

SELL
$92.01 - $123.21 $3,864 - $5,174
-42 Reduced 0.38%
11,140 $1.05 Million
Q4 2017

Jan 31, 2018

SELL
$89.56 - $98.21 $934,200 - $1.02 Million
-10,431 Reduced 48.26%
11,182 $1.08 Million
Q3 2017

Nov 06, 2017

BUY
$69.85 - $89.22 $1.51 Million - $1.93 Million
21,613
21,613 $1.92 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cliftonlarsonallen Wealth Advisors, LLC Portfolio

Follow Cliftonlarsonallen Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cliftonlarsonallen Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cliftonlarsonallen Wealth Advisors, LLC with notifications on news.